NCT01993173View on ClinicalTrials.gov

Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.

PHASE3CompletedINTERVENTIONAL
Enrollment

1,440

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

April 30, 2015

Conditions
DiphtheriaTetanusPertussis
Interventions
BIOLOGICAL

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap (ADACEL)

0.5 mL, Intramuscular

BIOLOGICAL

DT vaccine (Diphtheria and Tetanus Combined Vaccine, Adsorbed)

0.5 mL, Intramuscular

BIOLOGICAL

Td vaccine (Diphtheria and Tetanus Combined Vaccine for Adults and Adolescents, Adsorbed)

0.5 mL, Intramuscular

Trial Locations (1)

Unknown

Yandu

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01993173 - Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China. | Biotech Hunter | Biotech Hunter